Particularly, spending for controller drugs grew from $280 million to $2.1 billion and for reliever drugs, the increase was $222 million to $352 million . Source Company for Healthcare Quality and Research.. AHRQ: Asthma drug usage among children doubles The proportion of children who used a prescribed controller drug to take care of their asthma doubled from 29 % in 1997-1998 to 58 % in 2007-2008, based on the latest Information and Numbers from the Agency for Health care Research and Quality.The scholarly study found that among children with rare or aggressive cancers, genetic sequencing revealed potentially ‘actionable findings’ in almost half of them. For a few, that meant a switch in analysis; for others, an inherited gene mutation was found, which allowed various other family members to be tested. And for ten % of the small children, doctors were able to begin therapy with a more recent, ‘targeted’ cancer medication that either temporarily defeat the cancer back, or brought a complete remission. On the surface, those true numbers might not seem very encouraging, said lead researcher Dr. Rajen Mody, a pediatric oncologist at the University of Michigan C.S.